Clinical assessment of carotid atherosclerosis inflammation by positron emission tomography.

Curr Mol Med

Division of Brain Sciences, Department of Medicine, 5th Floor, Burlington Danes Building, Imperial College London, Hammersmith Hospital, London W12 0NN, UK.

Published: December 2013

Stroke caused by carotid atherosclerosis is a leading cause of mortality and the leading cause of disability in the developed world. For carotid plaques within the neurovascular territory of a recent stroke or transient ischaemic attack, surgical removal of the plaque (endarterectomy) has been clearly shown to reduce future cerebrovascular events. Management of asymptomatic plaques, however, is less clear because only a minority of these plaques will ultimately become symptomatic. Inflammation is a key feature which predicts whether a plaque is likely to rupture and hence lead to stroke. By identifying inflammation in vivo, positron emission tomography (PET) may be able to identify high risk plaques. This will allow clinicians to target intensive medical or surgical treatment to high risk patients.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1566524013666131111130334DOI Listing

Publication Analysis

Top Keywords

carotid atherosclerosis
8
positron emission
8
emission tomography
8
plaques will
8
high risk
8
clinical assessment
4
assessment carotid
4
atherosclerosis inflammation
4
inflammation positron
4
tomography stroke
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!